Rezolute, Inc. Common Stock (NV) (RZLT) is a publicly traded Healthcare sector company. As of July 28, 2026, RZLT trades at $4.98 with a market cap of $480.50M and a P/E ratio of -5.03. RZLT moved -0.81% today. Year to date, RZLT is +109.32%; over the trailing twelve months it is -21.59%. Its 52-week range spans $1.07 to $11.46. Analyst consensus is strong buy with an average price target of $8.43. Rallies surfaces RZLT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for RZLT shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $4.98 |
| Market Cap | $480.50M |
| P/E Ratio | -5.03 |
| EPS | $-0.98 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.46 |
| 52-Week Low | $1.07 |
| Volume | 176.59K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-74.41M |
| Gross Margin | 0.00% |
8 analysts cover RZLT: 0 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.43.